Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

  • 02:00

    Professor Miles Prince Interview (ICDO)

    in Health

    An interview with Professor Miles Prince, Melbourne, Australia. This pre-record is for 28FEB2010 Rare Disease Day Blogcast.

  • 02:00

    Castleman's Disease Patients and Researchers . . . Leading the Charge and Working Together!"

    in Health

    ICDO hosted a one-day summit December 2, 2009 in New Orleans, ahead of the 51st American Society of Hematology (ASH) Annual Meeting. Sponsored by Johnson & Johnson Pharmaceutical, Research & Development, LLC and OrthoBiotech, the summit is intended to foster awareness and understanding of Castleman’s Disease (CD), a rare disorder characterized by non-cancerous growths that develop in the lymph node tissue at a single site or throughout the body. An international panel of medical experts were present to discuss diagnosis and treatment options. Several patients provided their perspective on living with the disease.

  • 01:30

    An Interview with Jerry Zeldis, MD, PhD (pre-recorded)

    in Health

    Dr Zeldis is CEO of Celgene Global Health and Chief Medical Officer of Celgene Corporation, Summit, NJ. Prior to that he was Celgene’s Senior Vice President of Clinical Research and Medical Affairs. Dr. Zeldis attended Brown University for an A.B., M.S., followed by Yale University for an M.Phil, M.D., Ph.D. in Molecular Biophysics and Biochemmistry (immunochemistry. Dr Zeldis trained in Internal Medicine at the UCLA Center for the Health Sciences and Gastroenterology at the Massachusetts General Hospital and Harvard School of Medicine. He was Assistant Professor of Medicine at University of California, Davis, Clinical Associate Professor of Medicine at Cornell Medical School and Professor of Clinical Medicine at the Robert Wood Johnson Medical School in New Brunswick, New Jersey. Dr. Zeldis is currently on the International Castlemans Disease Organization (ICDO) and was past ICDO Medical Director.

  • 00:45

    Castleman's Disease Premiere

    in Health

    Castleman's Disease (CD) is a rare disease categorized as non-Hodgkin. The International Castleman's Disease Organization (ICDO) is a patient advocacy network created to provide patient information on this rare disease, introduce CD “centers of excellence”, and refer patients to clinicians responsible for treating a diagnosis of Castleman’s Disease. This premiere International Castleman’s Disease show will introduce a new health program series to BlogTalkRadio (BTR) that will openly discuss issues related to patient advocacy. Our broadcast will reach patients of the International Castleman’s Disease Organization in the U.S. and abroad. An aggressive CD BTR schedule is planned that will present academic medical facilities involved with treating CD patients and introductions from each of the ICDO Board of Directors.

  • 01:00

    Dr. Guido J.K.Tricot, MD, PhD, Professor, Department of Medicine; Salt Lake City, UT

    in Health

    Dr Tricot is the “Professor, Department of Medicine; Director, Utah Blood and Marrow Transplant and Myeloma Program," Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. This interview will encompass the capability of Huntsman Cancer Institute to provide Castlemans Disease patients with a diagnosis and treatment plan for this rare disease. In addition to capabilities and treatment, Dr. Tricot will discuss clinical trials available at Huntsman and an overview of the relation between Multiple Myeloma and Castleman’s Disease. A specific definition of what is Castleman's, the risk factors involved and other related diseases to a Castleman’s will be reviewed.

  • 01:00

    Frits VanRhee, MD, PhD., Professor of Medicine, UAMS Little Rock, AR

    in Health

    This presentation is an International Castlemans Disease Organization interview with Dr Frits Van Rhee, Professor of Medicine and Director of Clinical Research for the Myeloma Institute for Research and Therapy University of Arkansas for Medical Sciences, Little Rock, AR. Dr Van Rhee will be discussing the research, diagnosis and treatment of Castlemans Disease at the University of Arkansas for Medical Sciences. Under the direction of Dr Bart Barlogie, Professor of Medicine and Pathology and Director, Myeloma the Institute UAMS is one of the premiere facilities treating Castlemans Disease world-wide.

  • 01:00

    Dr. Kenneth Anderson and Dr. Nikhil Munshi Interview

    in Health

    Dr. Kenneth Anderson is the Craft Family Professor of Medicine at Harvard Medical School and Chief, Division of Hematologic Neoplasia, Dana Farber Cancer Institute. Dr Anderson is also the ICDO Chief Medical Officer and Scientific Advisory Board, chair. Dr. Nikhil Munshi is an Associate Professor of Medicine, Dana Farber Cancer Institute. An open discussion with Dr Anderson and Dr Munshi will include an overview of the Dana Farber Cancer Institute, specific affiliation to Castlemans Disease, DFC treatment plans and therapies.
    Dr. Anderson and Dr. Munshi will discuss the Dana Farber Cancer Institute’s contribution to the research and treatment of Castlemans Disease at the DFCI / Harvard Medical School.